胺碘酮、伊布利特序贯治疗新发持续性房颤及其对跨壁复极异质性的影响
DOI:
作者:
作者单位:

(信阳市中心医院心内科一病区, 河南省信阳市464000)

作者简介:

李俊桥,硕士,主治医师,研究方向为心律失常,E-mail为lijunqiaoxy@163.com。

通讯作者:

基金项目:


Effects of amiodarone and ibutilide sequential treatment on efficacy and transmural dispersion of repolarization in cardioversion of new persistent atrial fibrillation
Author:
Affiliation:

The First Ward, Department of Cardiology, Xinyang Central Hospital, Xinyang, Henan 464000, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨胺碘酮、伊布利特序贯治疗新发持续性房颤(PAF)及其对跨壁复极异质性的影响。方法 选取76例新发PAF患者,随机分为伊布利特组(38例)和序贯组(38例)。伊布利特组患者应用伊布利特1 mg(或0.01 mg/kg)稀释后匀速注射10 min,如果失败,相隔10 min后再以同样的剂量及方法二次给药;序贯组患者先用胺碘酮150 mg稀释后匀速注射10 min,如果失败,相隔10 min后再用伊布利特1 mg(或0.01 mg/kg)稀释后匀速注射10 min。比较两组患者二次用药后24 h内的房颤转复成功率、室性心律失常发生率,检测用药前及用药结束即刻、用药后30 min、1 h、3 h、4 h QT 间期和Tpeak-end/QT 间期比值的变化。结果 在第1次注药后,伊布利特的房颤转复成功率高于胺碘酮(P<0.05);二次注药合计,两组的房颤转复成功率比较差异无统计学意义(P>0.05);在转复成功患者中,序贯组伊布利特个体用药量显著小于伊布利特组(P<0.01);用药结束即刻及用药后30 min伊布利特组患者的Tpeak-end/QT均高于序贯组(均P<0.01);伊布利特组患者的Tpeak-end/QT于用药结束即刻开始显著升高(P<0.05),至用药后1 h恢复至用药前水平(P>0.05);序贯组患者的Tpeak-end/QT用药后各个时间点与用药前比较差异均无统计学意义(P>0.05)。结论 伊布利特房颤转复率高于胺碘酮,但单用伊布利特后跨壁复极异质性(Tpeak-end/QT)增加;先用一次胺碘酮后再用一次伊布利特,与二次单用伊布利特相比,房颤转复成功率相当,跨壁复极异质性(Tpeak-end/QT)没有增加,并有降低室性心律失常发生率的趋势。

    Abstract:

    Aim To study the effects of first using amiodarone and then using ibutilide on efficacy and transmural dispersion of repolarization in cardioversion of new(7 d~90 d) persistent atrial fibrillation(PAF).Methods 76 patients of new PAF were randomly divided into two groups:ibutilide group (38 cases) and sequential group (38 cases). Patients(38 cases) in the ibutilide group were treated with ibutilide intravenous injection, initial dose 1 mg(or 0.01 mg/kg), slow injection after dilution; amiodarone group(50 cases) were treated with amiodarone intravenous injection on conversion, initial dose 150 mg, diluted uniform injection for 10 min. If it failed, the same dose and method were used for the second time at intervals of 10 min; Patients(38 cases) in the sequential group were first diluted with amiodarone at 150 mg and then injected with it at a constant rate for 10 min. If it failed, 1 mg (or 0.01 mg/kg) of ibutilide was used to dilute the solution and then inject at a constant rate for 10 min. The success rate of atrial fibrillation recovery within 24 h after second administration, the incidence of ventricular arrhythmia were compared between two groups, changes in the ratios of QT interval and Tpeak-end/QT interval ratio (30 min, 1 h, 3 h, 4 h) were detected. Results After the first injection, the success rate of atrial fibrillation was higher than that of amiodarone(P<0.05); Total reinjection, comparison of the success rate of PAF reversion between the two groups (P>0.05), showed no significant difference. In patients with successful outcome, the dosages of ibutilide individuals in the sequential group were significantly lower than that in the ibutilide group(P<0.01); Tpeak-end/QT in the ibutilide group was higher than that in the sequential group immediately after medication and 30 min after medication(P<0.01); The tpeak-end /QT of the ibutilide group was significantly increased immediately after the end of the treatment(P<0.05), after 1 h of administration, the drug returned to the level before administration(P>0.05); Comparison of each time point after administration and before administration showed that there was no statistically significant difference of the Tpeak-end/QT in the sequential group(P>0.05). Conclusion The atrial fibrillation conversion rate of ibutilide was higher than that of amiodarone, however, the transmural dispersion of repolarization(Tpeak-end/QT) increased after ibutilide alone; for first using amiodarone and then using ibutilide, compared to the single usage of ibutilide for twice, the success rate of atrial fibrillation is comparable, the transmural dispersion of repolarization(Tpeak-end/QT)do not increase, there is a tendency to reduce the incidence of ventricular arrhythmia.

    参考文献
    相似文献
    引证文献
引用本文

李俊桥,申红梅,郭磊,杨贵宝,袁俊强.胺碘酮、伊布利特序贯治疗新发持续性房颤及其对跨壁复极异质性的影响[J].中国动脉硬化杂志,2019,27(5):426~431.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2018-08-15
  • 最后修改日期:2018-12-19
  • 录用日期:
  • 在线发布日期: 2019-04-08